换一批摘要With the prolongation of life, immune thrombocytopenia (ITP) is becoming more and more frequent in the elderly. At present,the research object of ITP is mainly aimed at children and adults,and there is less research on the elderly. The therapeutic strategy differs from that for younger patients and must consider the greater risk of bleeding and thrombosis,poor life expectancy and concomitant medications. This review summarizes the current status of treatment for elderly patients with ITP.
更多相关知识
关键词
免疫性血小板减少症老年人利妥昔单抗促血小板生成药物脾切除immune thrombocytopeniaelderlyrituximabplatelet stimulating agentsplenectomy
分类号
R558.2（血液及淋巴系疾病）
栏目名称
DOI
10.13201/j.issn.1004-2806.2018.05.018
发布时间
2018-08-30（万方平台首次上网日期，不代表论文的发表时间）
- 浏览26
- 被引7
- 下载0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
